Daiwa Securities Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2K | Hold |
404
| – | – | ﹤0.01% | 1235 |
|
2025
Q1 | $2K | Hold |
404
| – | – | ﹤0.01% | 1203 |
|
2024
Q4 | $1K | Hold |
404
| – | – | ﹤0.01% | 1275 |
|
2024
Q3 | $1K | Hold |
404
| – | – | ﹤0.01% | 1263 |
|
2024
Q2 | $1K | Hold |
404
| – | – | ﹤0.01% | 1297 |
|
2024
Q1 | $1K | Hold |
404
| – | – | ﹤0.01% | 1303 |
|
2023
Q4 | $1K | Hold |
404
| – | – | ﹤0.01% | 1302 |
|
2023
Q3 | $1K | Hold |
404
| – | – | ﹤0.01% | 1274 |
|
2023
Q2 | $1K | Hold |
404
| – | – | ﹤0.01% | 1297 |
|
2023
Q1 | $1K | Hold |
404
| – | – | ﹤0.01% | 1277 |
|
2022
Q4 | $1K | Hold |
404
| – | – | ﹤0.01% | 1287 |
|
2022
Q3 | $1K | Hold |
404
| – | – | ﹤0.01% | 1308 |
|
2022
Q2 | $1K | Hold |
404
| – | – | ﹤0.01% | 1315 |
|
2022
Q1 | $1K | Buy |
404
+302
| +296% | +$748 | ﹤0.01% | 1338 |
|
2021
Q4 | $0 | Hold |
102
| – | – | ﹤0.01% | 1446 |
|
2021
Q3 | $0 | Hold |
102
| – | – | ﹤0.01% | 1338 |
|
2021
Q2 | $0 | Hold |
102
| – | – | ﹤0.01% | 1288 |
|
2021
Q1 | $0 | Hold |
102
| – | – | ﹤0.01% | 1289 |
|
2020
Q4 | $1K | Sell |
102
-68
| -40% | -$667 | ﹤0.01% | 1211 |
|
2020
Q3 | $1K | Hold |
170
| – | – | ﹤0.01% | 1160 |
|
2020
Q2 | $0 | Hold |
170
| – | – | ﹤0.01% | 1202 |
|
2020
Q1 | $0 | Hold |
170
| – | – | ﹤0.01% | 1215 |
|
2019
Q4 | $1K | Hold |
170
| – | – | ﹤0.01% | 1178 |
|
2019
Q3 | $2K | Hold |
170
| – | – | ﹤0.01% | 1124 |
|
2019
Q2 | $2K | Hold |
170
| – | – | ﹤0.01% | 1138 |
|
2019
Q1 | $2K | Sell |
170
-130
| -43% | -$1.53K | ﹤0.01% | 1129 |
|
2018
Q4 | $5K | Buy |
+300
| New | +$5K | ﹤0.01% | 1050 |
|